BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 25490447)

  • 21. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide analysis of DNA methylation in pigs using reduced representation bisulfite sequencing.
    Choi M; Lee J; Le MT; Nguyen DT; Park S; Soundrarajan N; Schachtschneider KM; Kim J; Park JK; Kim JH; Park C
    DNA Res; 2015 Oct; 22(5):343-55. PubMed ID: 26358297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
    Raval A; Lucas DM; Matkovic JJ; Bennett KL; Liyanarachchi S; Young DC; Rassenti L; Kipps TJ; Grever MR; Byrd JC; Plass C
    J Clin Oncol; 2005 Jun; 23(17):3877-85. PubMed ID: 15809452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
    Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.
    Martinelli S; Kanduri M; Maffei R; Fiorcari S; Bulgarelli J; Marasca R; Rosenquist R
    Epigenetics; 2013 Jul; 8(7):720-9. PubMed ID: 23803577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.
    Cahill N; Bergh AC; Kanduri M; Göransson-Kultima H; Mansouri L; Isaksson A; Ryan F; Smedby KE; Juliusson G; Sundström C; Rosén A; Rosenquist R
    Leukemia; 2013 Jan; 27(1):150-8. PubMed ID: 22922567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics.
    Speedy HE; Beekman R; Chapaprieta V; Orlando G; Law PJ; Martín-García D; Gutiérrez-Abril J; Catovsky D; Beà S; Clot G; Puiggròs M; Torrents D; Puente XS; Allan JM; López-Otín C; Campo E; Houlston RS; Martín-Subero JI
    Nat Commun; 2019 Aug; 10(1):3615. PubMed ID: 31399598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact.
    Tong WG; Wierda WG; Lin E; Kuang SQ; Bekele BN; Estrov Z; Wei Y; Yang H; Keating MJ; Garcia-Manero G
    Epigenetics; 2010 Aug; 5(6):499-508. PubMed ID: 20484983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia.
    Chim CS; Pang R; Liang R
    J Clin Pathol; 2008 Nov; 61(11):1214-9. PubMed ID: 18765431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression and epigenetic deregulation.
    Shaknovich R
    Adv Exp Med Biol; 2013; 792():133-50. PubMed ID: 24014295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.
    Smith EN; Ghia EM; DeBoever CM; Rassenti LZ; Jepsen K; Yoon KA; Matsui H; Rozenzhak S; Alakus H; Shepard PJ; Dai Y; Khosroheidari M; Bina M; Gunderson KL; Messer K; Muthuswamy L; Hudson TJ; Harismendy O; Barrett CL; Jamieson CH; Carson DA; Kipps TJ; Frazer KA
    Blood Cancer J; 2015 Apr; 5(4):e303. PubMed ID: 25860294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.
    Wierzbinska JA; Toth R; Ishaque N; Rippe K; Mallm JP; Klett LC; Mertens D; Zenz T; Hielscher T; Seifert M; Küppers R; Assenov Y; Lutsik P; Stilgenbauer S; Roessner PM; Seiffert M; Byrd J; Oakes CC; Plass C; Lipka DB
    Genome Med; 2020 Mar; 12(1):29. PubMed ID: 32188505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
    Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
    Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability.
    Derrien J; Guérin-Charbonnel C; Gaborit V; Campion L; Devic M; Douillard E; Roi N; Avet-Loiseau H; Decaux O; Facon T; Mallm JP; Eils R; Munshi NC; Moreau P; Herrmann C; Magrangeas F; Minvielle S
    Genome Med; 2021 Aug; 13(1):127. PubMed ID: 34372935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior.
    Rahmatpanah FB; Carstens S; Guo J; Sjahputera O; Taylor KH; Duff D; Shi H; Davis JW; Hooshmand SI; Chitma-Matsiga R; Caldwell CW
    Leukemia; 2006 Oct; 20(10):1855-62. PubMed ID: 16900213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Base-Resolution Analysis of DNA Methylation Patterns Downstream of
    Duncan CG; Kondilis-Mangum HD; Grimm SA; Bushel PR; Chrysovergis K; Roberts JD; Tyson FL; Merrick BA; Wade PA
    G3 (Bethesda); 2018 Mar; 8(3):805-813. PubMed ID: 29326230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia.
    Fülöp Z; Csernus B; Tímár B; Szepesi A; Matolcsy A
    Leukemia; 2003 Feb; 17(2):411-5. PubMed ID: 12592341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
    Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
    BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming.
    Wu J; Xu X; Lee EJ; Shull AY; Pei L; Awan F; Wang X; Choi JH; Deng L; Xin HB; Zhong W; Liang J; Miao Y; Wu Y; Fan L; Li J; Xu W; Shi H
    Oncotarget; 2016 Jun; 7(26):40558-40570. PubMed ID: 27302925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisulfite Conversion of DNA: Performance Comparison of Different Kits and Methylation Quantitation of Epigenetic Biomarkers that Have the Potential to Be Used in Non-Invasive Prenatal Testing.
    Leontiou CA; Hadjidaniel MD; Mina P; Antoniou P; Ioannides M; Patsalis PC
    PLoS One; 2015; 10(8):e0135058. PubMed ID: 26247357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.